Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets

v3.8.0.1
Balance Sheets - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 23,955,397 $ 5,127,958
Escrowed cash receivable 3,750,803 0
Grants receivable 30,135 132,472
Prepaid expenses and other current assets 341,025 391,253
Restricted cash, current portion 29,159 11,111
Total current assets 28,106,519 5,662,794
Property and equipment, net 34,183 43,243
Restricted cash, net of current portion 62,847 62,828
Total assets 28,203,549 5,768,865
Current liabilities:    
Term debt, net of discount 0 2,353,667
Accounts payable 312,514 1,010,209
Accrued expenses and other current liabilities 1,290,683 947,987
Income taxes payable 3,230,000 0
Total current liabilities 4,833,197 4,311,863
License obligations 1,250,000 1,250,000
Total liabilities 6,083,197 5,561,863
Stockholders’ equity:    
Preferred stock—$0.001 par value; 5,000,000 shares authorized; zero shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 0 0
Common stock—$0.001 par value; 200,000,000 shares authorized; 26,054,857 and 9,434,141 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 26,055 9,434
Additional paid-in capital 77,167,922 70,232,651
Accumulated deficit (55,073,625) (70,035,083)
Total stockholders’ equity 22,120,352 207,002
Total liabilities and stockholders’ equity $ 28,203,549 $ 5,768,865